DIABETE TYPE 2

This early-stage study will test whether a drug called Henggliejin can improve fatty liver in people who have both type 2 diabetes and nonalcoholic fatty liver disease (NAFLD). About 149 adults will take the drug for 48 weeks, and doctors will check liver health using a simple bl…

This study tests a new way to manage care for older adults (ages 60-74) who have both high blood pressure and type 2 diabetes in rural China. About 960 people from community health centers will either receive the new integrated care package or continue with standard care. The goa…

This study tests a probiotic called LP-LDL® in 210 adults with prediabetes or type 1 or type 2 diabetes who also have high cholesterol or triglycerides. Participants take either the probiotic or a placebo daily for 12 weeks. Researchers will measure changes in cholesterol, blood …

This early study tests if injecting a person's own fat-derived stem cells into the upper intestine is safe and can improve blood sugar control in type 2 diabetes. The goal is to help the body respond better to insulin and manage the disease long-term. Fifteen adults with type 2 d…

This study looks at whether eating 3 dates each day for 8 weeks can improve blood sugar control and reduce oxidative stress in people with well-controlled type 2 diabetes. Researchers will replace a carbohydrate portion in the diet with dates to see if it helps without raising bl…

This study compares two diabetes medications, empagliflozin and glimepiride, added to standard treatment in 200 adults with type 2 diabetes. The goal is to see which combination better controls blood sugar, avoids weight gain, and prevents low blood sugar episodes. Participants m…

This study looks at whether a special therapy called Intraneural Facilitation (INF) and a diet plan can help people with type 2 diabetes who have nerve pain in their feet and legs. About 60 adults aged 35 to 85 will be split into three groups: one gets the therapy alone, one gets…

This study looks at how a class of diabetes drugs called SGLT2i affects the balance between the 'fight or flight' and 'rest and digest' nervous systems in people with type 2 diabetes. Researchers will monitor heart rate patterns in 150 adults who also have heart failure, chronic …